Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research

Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research

Published

News published by Savara Inc. concerning Molgramostim Nebulizer Solution, a novel investigational inhaled biologic, administered via an investigational eFlow® Technology nebulizer.
 

Read the press release

Back to overview